4.6 Article

Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation

期刊

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 45, 期 1-2, 页码 169-183

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2011.11.004

关键词

Butyrylcholinesterase; Inhibition Imidazole; ChemGPS-NP; Lead refinement; Acetylcholinesterase

资金

  1. National Doctoral Programme in Informational and Structural Biology (ISB)
  2. Academy of Finland (BIOARMI) [128870]
  3. Drug Discovery and Chemical Biology (DDCB) network of Biocenter Finland
  4. Academy of Finland (AKA) [128870, 128870] Funding Source: Academy of Finland (AKA)

向作者/读者索取更多资源

In this contribution, a chemical collection of aromatic compounds was screened for inhibition on butyrylcholinesterase (BChE)'s hydrolase activity using Ellman's reaction. A set of diarylimidazoles was identified as highly selective inhibitors of BChE hydrolase activity and amyloid beta (A beta) fibril formation. New derivatives were synthesized resulting in several additional hits, from which the most active was 6c, 4-(3-ethylthiophenyl)-2-(3-thieny1)-1H-imidazole, an uncompetitive inhibitor of BChE hydrolase activity (IC50 BChE = 0.10 mu M; K-i = 0.073 +/- 0.011 mu M) acting also on Ap fibril formation (IC50 = 5.8 mu M). With the aid of structure-activity relationship (SAR) studies, chemical motifs influencing the BChE inhibitory activity of these imidazoles were proposed. These bifunctional inhibitors represent good tools in basic studies of BChE and/or promising lead molecules for AD therapy. (C) 2011 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据